Vectus Biosystems Limited
ASX:VBS.AX
Overview | Financials
Company Name | Vectus Biosystems Limited |
Symbol | VBS.AX |
Currency | AUD |
Price | 0.08 |
Market Cap | 4,256,840 |
Dividend Yield | 0% |
52-week-range | 0.076 - 0.37 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Karen Annette Duggan |
Website | https://www.vectusbiosystems.com.au |
An error occurred while fetching data.
About Vectus Biosystems Limited
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD